Skip to Content

Dermaxon Logo Dermaxon

Further exploring the brain-skin connection for a better life

May 2018

DermaXon presented at the 2018 Society for Investigative Dermatology Annual meeting, May 2018, Orlando, USA. Results presented confirmed the efficacy of our one of CYP26 inhibitors in modulating epidermal barrier function.

< Back to News
^ Back to Top ^ Back to Top
MENU